Cyclooxygenase-2 Up-regulates CCR7 via EP2/EP4 Receptor Signaling Pathways to Enhance Lymphatic Invasion of Breast Cancer Cells*

This publication has 26 references indexed in Scilit:

• Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer
  British Journal of Cancer, 2007
• Silencing of the Metastasis Suppressor RECK by RAS Oncogene Is Mediated by DNA Methyltransferase 3b–Induced Promoter Methylation
  Cancer Research, 2006
• COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
  British Journal of Cancer, 2006
• Novel immunosuppressive properties of interleukin‐6 in dendritic cells: inhibition of NF‐κB binding activity and CCR7 expression
  The FASEB Journal, 2004
• Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
  The FASEB Journal, 2004
• Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated Kinases
  Journal of Biological Chemistry, 2003
• Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
  Blood, 2002
• Cyclooxygenase-2: A Therapeutic Target
  Annual Review of Medicine, 2002
• Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells
  Journal of Biological Chemistry, 2001
• Cyclooxygenases: Structural, Cellular, and Molecular Biology
  Annual Review of Biochemistry, 2000